Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Optogenetic control of the lac operon for bacterial chemical and protein production

Abstract

Control of the lac operon with isopropyl β-d-1-thiogalactopyranoside (IPTG) has been used to regulate gene expression in Escherichia coli for countless applications, including metabolic engineering and recombinant protein production. However, optogenetics offers unique capabilities, such as easy tunability, reversibility, dynamic induction strength and spatial control, that are difficult to obtain with chemical inducers. We have developed a series of circuits for optogenetic regulation of the lac operon, which we call OptoLAC, to control gene expression from various IPTG-inducible promoters using only blue light. Applying them to metabolic engineering improves mevalonate and isobutanol production by 24% and 27% respectively, compared to IPTG induction, in light-controlled fermentations scalable to at least two-litre bioreactors. Furthermore, OptoLAC circuits enable control of recombinant protein production, reaching yields comparable to IPTG induction but with easier tunability of expression. OptoLAC circuits are potentially useful to confer light control over other cell functions originally designed to be IPTG-inducible.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: OptoLAC circuits design.
Fig. 2: OptoLAC circuit characterization.
Fig. 3: Dynamic control of isobutanol production using OptoLAC circuits.
Fig. 4: Dynamic control of mevalonate production using OptoLAC circuits and scale-up.
Fig. 5: Light-controlled recombinant protein production in E. coli B strain (OptoBL).

Similar content being viewed by others

Data availability

All data supporting the findings of this study are available within the paper and Supplementary Information. Source data are provided with this paper.

References

  1. Pontrelli, S. et al. Escherichia coli as a host for metabolic engineering. Metab. Eng. 50, 16–46 (2018).

    CAS  PubMed  Google Scholar 

  2. Sanford, K., Chotani, G., Danielson, N. & Zahn, J. A. Scaling up of renewable chemicals. Curr. Opin. Biotechnol. 38, 112–122 (2016).

    CAS  PubMed  Google Scholar 

  3. Burgard, A., Burk, M. J., Osterhout, R., Van Dien, S. & Yim, H. Development of a commercial scale process for production of 1,4-butanediol from sugar. Curr. Opin. Biotechnol. 42, 118–125 (2016).

    CAS  PubMed  Google Scholar 

  4. Lalwani, M. A., Zhao, E. M. & Avalos, J. L. Current and future modalities of dynamic control in metabolic engineering. Curr. Opin. Biotechnol. 52, 56–65 (2018).

    CAS  PubMed  Google Scholar 

  5. Zhao, E. M. et al. Optogenetic regulation of engineered cellular metabolism for microbial chemical production. Nature 555, 683–687 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Jacob, F. & Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318–356 (1961).

    CAS  PubMed  Google Scholar 

  7. Donovan, R. S., Robinson, C. W. & Click, B. R. Review: optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J. Ind. Microbiol. 16, 145–154 (1996).

    CAS  PubMed  Google Scholar 

  8. Levskaya, A. Engineering Escherichia coli to see light. Nature 438, 441–442 (2005).

    CAS  PubMed  Google Scholar 

  9. Tabor, J. J., Levskaya, A. & Voigt, C. A. Multichromatic control of gene expression in Escherichia coli. J. Mol. Biol. 405, 315–324 (2011).

    CAS  PubMed  Google Scholar 

  10. Ohlendorf, R., Vidavski, R. R., Eldar, A., Moffat, K. & Möglich, A. From dusk till dawn: one-plasmid systems for light-regulated gene expression. J. Mol. Biol. 416, 534–542 (2012).

    CAS  PubMed  Google Scholar 

  11. Möglich, A. et al. Design and signaling mechanism of light-regulated histidine kinases. J. Mol. Biol. 385, 1433–1444 (2009).

    PubMed  Google Scholar 

  12. Orman, M. A. & Brynildsen, M. P. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57, 3230–3239 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Tu, G.-F., Reid, G. E., Zhang, J.-G., Moritz, R. L. & Simpson, R. J. C-terminal extension of truncated recombinant proteins in Escherichia coli with a 10Sa RNA decapeptide. J. Biol. Chem. 270, 9322–9326 (1995).

    CAS  PubMed  Google Scholar 

  14. Hentschel, E. et al. Destabilized eYFP variants for dynamic gene expression studies in Corynebacterium glutamicum. Microb. Biotechnol. 6, 196–201 (2013).

    PubMed  Google Scholar 

  15. Studier, F. W. & Moffatt, B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189, 113–130 (1986).

    CAS  PubMed  Google Scholar 

  16. Brosius, J., Erfle, M. & Storella, J. Spacing of the -10 and -35 regions in the tac promoter. Effect on its in vivo activity. J. Biol. Chem. 260, 3539–3541 (1985).

    CAS  PubMed  Google Scholar 

  17. Zhao, E. M. et al. Light-based control of metabolic flux through assembly of synthetic organelles. Nat. Chem. Biol. 15, 589–597 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D. & Keasling, J. D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 21, 796–802 (2003).

    CAS  PubMed  Google Scholar 

  19. Atsumi, S., Hanai, T. & Liao, J. C. Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451, 86–89 (2008).

    CAS  PubMed  Google Scholar 

  20. Baez, A., Cho, K. M. & Liao, J. C. High-flux isobutanol production using engineered Escherichia coli: a bioreactor study with in situ product removal. Appl. Microbiol. Biotechnol. 90, 1681–1690 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Goulas, T. et al. The pCri system: a vector collection for recombinant protein expression and purification. PLoS ONE 9, e112643 (2014).

    PubMed  PubMed Central  Google Scholar 

  22. Chang, A. C. Y. & Cohen, S. N. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134, 1141–1156 (1978).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Marin, A. M. et al. Naringenin degradation by the endophytic diazotroph Herbaspirillum seropedicae SmR1. Microbiology 159, 167–175 (2013).

    CAS  PubMed  Google Scholar 

  24. Baumschlager, A., Aoki, S. K. & Khammash, M. Dynamic blue light-inducible T7 RNA polymerases (Opto-T7RNAPs) for precise spatiotemporal gene expression control. ACS Synth. Biol. 6, 2157–2167 (2017).

    CAS  PubMed  Google Scholar 

  25. Chou, C., Young, D. D. & Deiters, A. Photocaged T7 RNA polymerase for the light activation of transcription and gene function in pro- and eukaryotic cells. ChemBioChem 11, 972–977 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Binder, D. et al. Light-responsive control of bacterial gene expression: precise triggering of the lac promoter activity using photocaged IPTG. Integr. Biol. 6, 755–765 (2014).

    CAS  Google Scholar 

  27. Wu, G. et al. Metabolic burden: cornerstones in synthetic biology and metabolic engineering applications. Trends Biotechnol. 34, 652–664 (2016).

    CAS  PubMed  Google Scholar 

  28. Hillson, N. et al. Building a global alliance of biofoundries. Nat. Commun. 10, 1038–1041 (2019).

    Google Scholar 

  29. Awan, A. R. et al. Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker’s yeast. Nat. Commun. 8, 15202 (2017).

    PubMed  PubMed Central  Google Scholar 

  30. Latimer, L. N. & Dueber, J. E. Iterative optimization of xylose catabolism in Saccharomyces cerevisiae using combinatorial expression tuning. Biotechnol. Bioeng. 114, 1301–1309 (2017).

    CAS  PubMed  Google Scholar 

  31. Hennemann, J. et al. Optogenetic control by pulsed illumination. ChemBioChem 19, 1296–1304 (2018).

    CAS  PubMed  Google Scholar 

  32. Diensthuber, R. P., Bommer, M., Gleichmann, T. & Möglich, A. Full-length structure of a sensor histidine kinase pinpoints coaxial coiled coils as signal transducers and modulators. Structure 21, 1127–1136 (2013).

    CAS  PubMed  Google Scholar 

  33. Ajikumar, P. K. et al. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 330, 70–74 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Melis, A. et al. Chromatic regulation in Chlamydomonas reinhardtii alters photosystem stoichiometry and improves the quantum efficiency of photosynthesis. Photosynth. Res. 47, 253–265 (1996).

    CAS  PubMed  Google Scholar 

  35. Ort, D. R., Zhu, X. & Melis, A. Optimizing antenna size to maximize photosynthetic efficiency. Plant Physiol. 155, 79–85 (2011).

    CAS  PubMed  Google Scholar 

  36. Nilsson, G., Belasco, J. G., Cohen, S. N. & Von Gabain, A. Growth-rate dependent regulation of mRNA stability in Escherichia coli. Nature 312, 75–77 (1984).

    CAS  PubMed  Google Scholar 

  37. Gottesman, S. Proteases and their targets in Escherichia coli. Annu. Rev. Genet. 30, 465–506 (1996).

    CAS  PubMed  Google Scholar 

  38. Doong, S. J., Gupta, A. & Prather, K. L. J. Layered dynamic regulation for improving metabolic pathway productivity in Escherichia coli. Proc. Natl Acad. Sci. USA 115, 2964–2969 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Valiyaveetil, F. I., MacKinnon, R. & Muir, T. W. Semisynthesis and folding of the potassium channel KcsA. J. Am. Chem. Soc. 124, 9113–9120 (2002).

    CAS  PubMed  Google Scholar 

  40. San-Miguel, T., Pérez-Bermúdez, P. & Gavidia, I. Production of soluble eukaryotic recombinant proteins in E. coli is favoured in early log-phase cultures induced at low temperature. Springerplus 2, 1–4 (2013).

    Google Scholar 

  41. Studier, F. W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207–234 (2005).

    CAS  PubMed  Google Scholar 

  42. Mok, W. W. K. & Brynildsen, M. P. Timing of DNA damage responses impacts persistence to fluoroquinolones. Proc. Natl Acad. Sci. USA 115, E6301–E6309 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Partridge, J. D., Nhu, N. T. Q., Dufour, Y. S. & Harshey, R. M. Escherichia coli remodels the chemotaxis pathway for swarming. mBio 10, 1–16 (2019).

    Google Scholar 

  44. McGinness, K. E., Baker, T. A. & Sauer, R. T. Engineering controllable protein degradation. Mol. Cell 22, 701–707 (2006).

    CAS  PubMed  Google Scholar 

  45. Zuo, R., Hashimoto, Y., Yang, L., Bentley, W. E. & Wood, T. K. Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J. Bacteriol. 188, 305–316 (2006).

    PubMed  PubMed Central  Google Scholar 

  46. Ronchel, M. C. et al. Characterization of cell lysis in Pseudomonas putida induced upon expression of heterologous killing genes. Appl. Environ. Microbiol. 64, 4904–4911 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Rittmann, D., Lindner, S. N. & Wendisch, V. F. Engineering of a glycerol utilization pathway for amino acid production by Corynebacterium glutamicum. Appl. Environ. Microbiol. 74, 6216–6222 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Nguyen, H. D., Phan, T. T. P. & Schumann, W. Expression vectors for the rapid purification of recombinant proteins in Bacillus subtilis. Curr. Microbiol. 55, 89–93 (2007).

    CAS  PubMed  Google Scholar 

  49. Inoue, H., Nojima, H. & Okayma, H. High efficiency transformation of Escherichia coli with plasmids. Gene 96, 23–28 (1990).

    CAS  PubMed  Google Scholar 

  50. Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).

    CAS  PubMed  Google Scholar 

  51. Atsumi, S. et al. Engineering the isobutanol biosynthetic pathway in Escherichia coli by comparison of three aldehyde reductase/alcohol dehydrogenase genes. Appl. Microbiol. Biotechnol. 85, 651–657 (2010).

    CAS  PubMed  Google Scholar 

  52. Zhou, K., Qiao, K., Edgar, S. & Stephanopoulos, G. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nat. Biotechnol. 33, 377–383 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Pédelacq, J. D., Cabantous, S., Tran, T., Terwilliger, T. C. & Waldo, G. S. Engineering and characterization of a superfolder green fluorescent protein. Nat. Biotechnol. 24, 79–88 (2006).

    PubMed  Google Scholar 

  54. Towbin, H., Staehellin, T. & Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350–4354 (1979).

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640–6645 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Lee, M. E., DeLoache, W. C., Cervantes, B. & Dueber, J. E. A highly characterized yeast toolkit for modular, multipart assembly. ACS Synth. Biol. 4, 975–986 (2015).

    CAS  PubMed  Google Scholar 

  57. Dower, W. J., Miller, J. F. & Ragsdale, C. W. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16, 6127–6145 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Cherepanov, P. P. & Wackernagel, W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158, 9–14 (1995).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank M. Brynildsen for strain MG1655 ΔlacI::FRT-KanR-FRT, A. Möglich for plasmids pDusk and pDawn, J. Keasling for plasmid pMevT and J. Liao for plasmids pSA65 and pSA69. We are very grateful to W. Mok and M. Brynildsen for advice and troubleshooting regarding E. coli protocols. We thank C. DeCoste, K. Rittenbach and the Princeton Molecular Biology Flow Cytometry Resource Center for assistance with flow cytometry experiments. J.L.A. is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research award no. DE-SC0019363, the NSF CAREER Award CBET-1751840, The Pew Charitable Trusts, The Eric and Wendy Schmidt Transformative Technology Fund Award and the Camille Dreyfus Teacher-Scholar Award.

Author information

Authors and Affiliations

Authors

Contributions

M.A.L. and J.L.A. conceived this project and designed the experiments. M.A.L., S.S.I. and C.C.-L. constructed the strains and plasmids. M.A.L. and S.S.I. performed the experiments shown in Figs. 1 and 2. M.A.L., E.M.Z. and H.K. performed the experiments shown in Figs. 3 and 4. M.A.L., C.C.-L. and C.D. performed the experiments shown in Fig. 5. M.A.L. performed experiments shown in Extended Data Figs. 110. C.C.-L. and C.D. performed experiments shown in Extended Data Figs. 2 and 9. M.A.L., C.C.-L. and J.L.A. analyzed the data and wrote the manuscript. J.L.A. supervised and funded the project.

Corresponding author

Correspondence to José L. Avalos.

Ethics declarations

Competing interests

J.L.A., M.A.L. and C.C.-L. have filed a patent application (‘Optogenetic circuits for controlling chemical and protein production in Escherichia coli’, US patent application 62,935,267) describing the OptoLAC circuit design and application for chemical and recombinant protein production.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Development of OptoLAC circuits.

a, GFP expression in blue light or darkness from the constitutive PBBA promoter (EMAL231) or from PT5-lacO in a strain in which lacI expression is controlled by pDawn (EMAL57). P = 0.07118. b, GFP expression in blue light or darkness from PBBA (EMAL231) or from PT5-lacO in strains containing the pDawn system controlling LacI fused to SsrA tags terminating in LAA (EMAL68, which gave rise to OptoLAC1), AAV (EMAL69, which gave rise to OptoLAC2), or ASV (EMAL71). From left to right: P < 0.00001, P < 0.00001, P = 0.00536. c, GFP expression in blue light or darkness driven by the PFixK2 (pMAL441) or PFixK2-lacO (pMAL442) promoter using pDusk (EMAL152 and EMAL153, respectively). P = 0.000037. **P < 0.01, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as median values of 10,000 single-cell flow cytometry events; error bars represent one standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 3 independent experiments.

Source data

Extended Data Fig. 2 Quantification of LacI protein levels for OptoLAC circuits.

Integrated peak volumes of LacI protein levels quantified via Western blot. From left to right: P = 0.00102, P = 0.000041. Loading controls and uncropped blots used for quantification (samples derived from the same experiment and processed in parallel) are provided as source data. ** P < 0.01, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as mean values; error bars represent the standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 2 independent experiments.

Source data

Extended Data Fig. 3 Response of OptoLAC circuits to IPTG.

GFP expression from PT5-lacO controlled by OptoLAC1 (orange, EMAL68), OptoLAC2 (purple, EMAL69), or OptoLAC3 (gray, EMAL230) under blue light with different concentrations of IPTG added at the time of inoculation. From left to right: P < 0.00001, P = 0.000076, P = 0.00692, P = 0.000025. **P < 0.01, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as median values of 10,000 single-cell flow cytometry events; error bars represent one standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 3 independent experiments.

Source data

Extended Data Fig. 4 Response of OptoLAC circuits to low temperatures.

GFP expression at 18 °C from PBBA (EMAL231) or PT5-lacO controlled by OptoLAC1 (EMAL68), OptoLAC2 (EMAL69), or OptoLAC3 (EMAL230) under blue light or darkness. From left to right: P < 0.00001, P = 0.000014, P = 0.0222. *P < 0.05, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as median values of 10,000 single-cell flow cytometry events; error bars represent one standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 3 independent experiments.

Source data

Extended Data Fig. 5 Tunability of OptoLAC circuits with light intensity.

GFP expression from the constitutive PBBA promoter (EMAL231) or from PT5-lacO controlled by OptoLAC1 (EMAL68) or OptoLAC3 (EMAL230) under continuous blue light of differing intensities or darkness. From left to right: P = 0.0189, P = 0.00314, P < 0.00001, P < 0.00001. *P < 0.05, **P < 0.01, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as median values of 10,000 single-cell flow cytometry events; error bars represent one standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 3 independent experiments.

Source data

Extended Data Fig. 6 Spatial control of GFP expression on an LB agar plate.

LB agar plate containing a lawn of EMAL68 (OptoLAC1 driving GFP) illuminated with a projection of a tiger image. Scale bar: 1 cm. Data are representative of n = 2 independent experiments.

Extended Data Fig. 7 Growth curves of K strains containing OptoLAC circuits under different induction conditions.

ac, OD600 measurements for strains containing OptoLAC1 (EMAL68; orange circle), OptoLAC2 (EMAL69; purple triangle), OptoLAC3 (EMAL230; gray square), or an IPTG-induced control (EMAL77; green diamond) using different induction conditions, shown on top of each graph as uninduced (blue) or induced (gray). a, Cultures of each strain grown under continuous blue light for 4 hours before switching them to darkness (OptoLAC circuits) or adding 1 mM IPTG (IPTG control). From left to right: P = 0.00827, P = 0.1472. b, Cultures grown entirely uninduced under continuous blue light (OptoLAC circuits) or without IPTG (IPTG control). From left to right: P = 0.00275, P = 0.0508. c, Cultures grown constitutively induced in darkness (OptoLAC circuits) or with 1 mM IPTG (IPTG control). From left to right: P = 0.000393, P = 0.00145, P = 0.33. **P < 0.01, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as mean values; error bars represent the standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 2 independent experiments.

Source data

Extended Data Fig. 8 Optimization of the cell density of induction with IPTG for chemical production.

a, Isobutanol production from pMAL534 by EMAL201 when induced with 1 mM IPTG at different cell densities. P = 0.819. b, Mevalonate production from pMAL487 by EMAL135 when induced with 1 mM IPTG at different cell densities. P = 0.02185. *P < 0.01. Statistics are derived using a two-sided t-test. All data shown as mean values; error bars represent the standard deviation of n = 4 biologically independent samples; open circles represent individual data points. Data are representative of n = 2 independent experiments.

Source data

Extended Data Fig. 9 Optimization of YFP and FdeR production using OptoLAC circuits.

a, YFP production when inducing at different cell densities (ρs) by switching cultures from blue light to darkness using OptoLAC1B (EMAL284, top panel) or adding IPTG (EMAL283, bottom panel). NI = Not induced: kept under blue light or no IPTG added. b, Comparison of FdeR production between OptoLAC1B (EMAL335) and OptoLAC2B (EMAL336) cultured under continuous blue light for 12 hours. c, FdeR production when inducing at different cell densities (ρs) by adding IPTG (EMAL329, top panel) or switching cultures from blue light to darkness using OptoLAC2B (EMAL336, bottom panel). NI = Not induced: kept under blue light or no IPTG added. All samples were resolved via SDS-PAGE (12% polyacrylamide). d, Tunability of YFP production using different doses of light or concentrations of IPTG, resolved and quantified via Western blot. From left to right: P = 0.0201, P = 0.000383, P = 0.000206. Loading controls and uncropped gels and blots, including those used for quantification in d (samples derived from the same experiment and processed in parallel) are provided as source data. *P < 0.05, ***P < 0.001. Statistics are derived using a two-sided t-test. All data shown as mean values; error bars represent the standard deviation of three biologically independent samples; open circles represent individual data points. Data are representative of n = 2 independent experiments.

Source data

Extended Data Fig. 10 Growth curves of B strains containing OptoLAC circuits under different induction conditions.

a, b, Time course of OD600 readings for BL21 DE3 (EMAL283; orange square), Rosetta 2 (EMAL276; green diamond), and OptoBL containing OptoLAC1B (EMAL284; black circle without IPTG, yellow circle with IPTG), containing plasmids for YFP production, grown under different induction conditions, which are shown on top of each graph as uninduced (blue) or induced (gray). a, Cultures from each strain grown under blue light before switching to the dark (OptoLAC1B) or adding IPTG. From left to right: P < 0.0122, P = 0.0946. b, Cultures grown entirely uninduced under blue light (OptoLAC1B), without IPTG, or OptoLAC1B with blue light and IPTG. From left to right: P = 0.00342, P = 0.0017. *P < 0.05, **P < 0.01. Statistics are derived using a two-sided t-test. All data shown as mean values; error bars represent the standard deviation of n = 3 biologically independent samples; open circles represent individual data points. Data are representative of n = 2 independent experiments.

Source data

Supplementary information

Supplementary Information

Supplementary Tables 1–2, Figs. 1–4 and Notes 1–9.

Reporting Summary

Source data

Source Data Fig. 1

Statistical source data.

Source Data Fig. 2

Statistical source data.

Source Data Fig. 3

Statistical source data.

Source Data Fig. 4

Statistical source data.

Source Data Fig. 5

Statistical source data.

Source Data Fig. 5

Unprocessed western blots and gels.

Source Data Extended Data Fig. 1

Statistical source data.

Source Data Extended Data Fig. 2

Statistical source data.

Source Data Extended Data Fig. 2

Unprocessed western blots and gels.

Source Data Extended Data Fig. 3

Statistical source data.

Source Data Extended Data Fig. 4

Statistical source data.

Source Data Extended Data Fig. 5

Statistical source data.

Source Data Extended Data Fig. 7

Statistical source data.

Source Data Extended Data Fig. 8

Statistical source data.

Source Data Extended Data Fig. 9

Statistical source data.

Source Data Extended Data Fig. 9

Unprocessed western blots and gels.

Source Data Extended Data Fig. 10

Statistical source data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lalwani, M.A., Ip, S.S., Carrasco-López, C. et al. Optogenetic control of the lac operon for bacterial chemical and protein production. Nat Chem Biol 17, 71–79 (2021). https://doi.org/10.1038/s41589-020-0639-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-020-0639-1

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research